anonymous
Guest
anonymous
Guest
To our patients and customers
We commit to scientific excellence and investment in biopharmaceutical research and development to provide innovative, high-quality medicines that address the unmet medical needs of patients with serious diseases. We apply scientific rigor to produce clinical and economic benefit through medicines that improve patients’ lives. We strive to make information about our commercialized medicines widely and readily available. We actively seek to improve access to care, advocate for policies that promote health equity, and help underserved patients access and afford the medicines they need.
The largest myth regarding American white-collar crime is that we struggle to understand it. Kind of like believing PhRMA or PBM executives gouging customers fails to elicit a response from our moral institutions to deal with corruption. Corruption, no matter how sophisticated it might be. But the truth is Americans across the United States of America believe and know, white collar crime is more harmful than a guy with a gun. And that white collar criminals with power are more a risk to our culture and way of life than common criminals on the street.
The fact today is, we see companies like our very own, Bristol Myers Squibb, bring in yet another superpredator this incredible year, in a "Year of Social Equity & Strife" to keep us strong, dominant and ultimately, wreak havoc on the people we say, we are committed to serving. An innovating, for profit company working just as hard to keep the moral institutions at bay from our 'behavior in conducting business' as finding solutions to unmet health need.